Zheng Quan Shi Bao Wang·2026-01-26 09:25Group 1 - The monkeypox concept sector increased by 3.13%, ranking 8th among concept sectors, with 50 stocks rising, including Cap Bio, Mike Bio, and Zhijiang Bio, which hit the 20% limit up [1] - Notable gainers in the monkeypox sector included Wanfu Bio, Zhifei Bio, and Baipu Sais, which rose by 16.23%, 14.87%, and 12.58% respectively [1] - The sector saw a net inflow of 1.526 billion yuan from main funds, with 46 stocks receiving net inflows, and 6 stocks exceeding 100 million yuan in net inflow [2] Group 2 - The top net inflow stock was Zhifei Bio, with a net inflow of 261 million yuan, followed by Zhongsheng Pharmaceutical, Junshi Bio, and Daan Gene with net inflows of 223 million yuan, 169 million yuan, and 165 million yuan respectively [2] - Daan Gene, Cap Bio, and Kewah Bio had the highest net inflow ratios at 46.21%, 29.57%, and 26.98% respectively [3] - The monkeypox concept sector's performance was supported by significant trading volumes, with stocks like Zhifei Bio and Daan Gene showing high turnover rates of 8.77% and 3.62% respectively [3][4]